Oramed Pharmaceuticals Inc (ORMP)
2.84
+0.12
(+4.41%)
USD |
NASDAQ |
Mar 27, 16:00
2.80
-0.04
(-1.41%)
Pre-Market: 08:30
Oramed Pharmaceuticals Total Liabilities (Quarterly): 57.66M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 57.66M |
September 30, 2023 | 82.66M |
June 30, 2023 | 5.659M |
March 31, 2023 | 9.632M |
December 31, 2022 | 10.49M |
September 30, 2022 | 11.29M |
June 30, 2022 | 9.254M |
March 31, 2022 | 10.00M |
November 30, 2021 | 11.76M |
August 31, 2021 | 11.48M |
May 31, 2021 | 11.30M |
February 28, 2021 | 12.22M |
November 30, 2020 | 12.76M |
August 31, 2020 | 11.75M |
May 31, 2020 | 12.04M |
February 29, 2020 | 13.79M |
November 30, 2019 | 13.98M |
August 31, 2019 | 15.27M |
May 31, 2019 | 15.88M |
February 28, 2019 | 16.46M |
November 30, 2018 | 14.74M |
August 31, 2018 | 16.28M |
May 31, 2018 | 18.00M |
February 28, 2018 | 17.77M |
November 30, 2017 | 18.80M |
Date | Value |
---|---|
August 31, 2017 | 19.47M |
May 31, 2017 | 19.98M |
February 28, 2017 | 20.51M |
November 30, 2016 | 20.94M |
August 31, 2016 | 16.64M |
May 31, 2016 | 5.322M |
February 29, 2016 | 5.667M |
November 30, 2015 | 1.342M |
August 31, 2015 | 1.526M |
May 31, 2015 | 0.802M |
February 28, 2015 | 0.641M |
November 30, 2014 | 0.863M |
August 31, 2014 | 1.009M |
May 31, 2014 | 0.527M |
February 28, 2014 | 0.3822M |
November 30, 2013 | 0.7004M |
August 31, 2013 | 0.529M |
May 31, 2013 | 0.6871M |
February 28, 2013 | 0.7093M |
November 30, 2012 | 0.575M |
August 31, 2012 | 1.517M |
May 31, 2012 | 0.5027M |
February 29, 2012 | 0.7442M |
November 30, 2011 | 0.5852M |
August 31, 2011 | 0.602M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.659M
Minimum
Jun 2023
82.66M
Maximum
Sep 2023
17.84M
Average
11.76M
Median
Nov 2021
Total Liabilities (Quarterly) Benchmarks
Inogen Inc | 121.38M |
Petros Pharmaceuticals Inc | 31.86M |
DIH Holding US Inc | -- |
NovaBay Pharmaceuticals Inc | 5.815M |
Palatin Technologies Inc | 24.94M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 220.55M |
Shareholders Equity (Quarterly) | 163.82M |